The University of Michigan will once again offer coverage for STD testing after more than 5,000 students urged the school to restore the coverage. They claimed that discontinuing it would be devastating to its most destitute students.
university looked at the possibility of billing insurance companies
for the STD exams, which would make it the students’ responsibility
to pay the costs insurance companies did not. In the last several
years, the health center saw its yearly testing and processing
expenses reach $600,000. This cost is expected to increase to nearly
$700,000 for the 2019 fiscal year.
administrators contemplated the idea of shifting the STD testing
costs, a large number of students were quick to condemn the move. A
petition, which was created by the Students of Equitable Health Care
at UM to get them to reconsider the idea, garnered 5,200 students in
just two days.
petition read that the university’s move would significantly affect
the lower-income students – the ones who have the most difficult
time getting medical care when the preventable STIs are left
untreated and lead to other serious complications such as PID. He
said the costs are not a savings but an increase in costs on those
less likely to have healthcare coverage.
The university dropped the idea, and the health center’s executive director said the payment process for STDs should not hinder any student looking to get tested and medical care.
Here’s what we've been up to recently.
It has been known for over 40 years that certain viruses can cause cancer. The first such “oncovirus” to be identified was Epstein-Barr virus (EBV), which was associated with lymphoma in 1964. Since then, several other human cancer viruses have been discovered; together, they account for an estimated 12% of malignancies worldwide.
Eva is a 20-year old college student on the East Coast. In 2007, she and her mother visited their family doctor for Eva's pre-college physical. While they were there, Eva got the first in a series of vaccine shots called Gardasil, which has been found to greatly reduce the risk of contracting HPV in young women ages 9 to 26.